Hepatitis C Hepatitis C 
There is no vaccine against hepatitis C.  Prevention includes harm reduction efforts among people who inject drugs, testing donated blood, and treatment of people with chronic infection.  Chronic infection can be cured more than 95% of the time with antiviral medications such as sofosbuvir or simeprevir.  Peginterferon and ribavirin were earlier generation treatments that had a cure rate of less than 50% and greater side effects. : 2015 version  While access to the newer treatments was expensive,  by 2022 prices had dropped dramatically in many countries  due to the introduction of generic versions of  medicines.  Those who develop cirrhosis or liver cancer may require a liver transplant.  Hepatitis C is the leading reason for liver transplantation, though the virus usually recurs after transplantation Hepatitis C Hepatitis C